Article

Pharmaceutical Executive

Pharmaceutical Executive

Pharmaceutical Executive-05-01-2001
Volume0
Issue 0

The Next Y2K

Author(s):

Mark E. Kolb

Companies Face Costly System Overhauls With New FDA Regulations

Articles in this issue
Policy: Task Masters
Pharmacia's Carrie Cox: HBA Woman of the Year
Friends of Complexity
Under Federal Fire
Task Force: Enter the Fixers
The Next Y2K

Newsletter

Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.

Subscribe Now!
Related Videos
Gen Li
Related Content
adobe.stock.com
August 13th 2025

Oikos Announces GLP-1 Inspired Drink Designed for Retaining Muscle Mass During Weight Loss

Nicholas Jacobus
Addressing Disparities in Psoriasis Trials: Takeda's Strategies for Inclusivity in Clinical Research
August 13th 2025

Addressing Disparities in Psoriasis Trials: Takeda's Strategies for Inclusivity in Clinical Research

Miranda Schmalfuhs
CIT Therapeutics and Institute for Follicular Lymphoma Innovation Launch Multimillion Dollar Partnership to Advance Cancer Therapy
August 13th 2025

CIT Therapeutics and Institute for Follicular Lymphoma Innovation Launch Multimillion Dollar Partnership to Advance Cancer Therapy

Don Tracy, Associate Editor
Beyond the Prescription: Pharma's Role in Digital Health Conversations
August 13th 2025

Beyond the Prescription: Pharma's Role in Digital Health Conversations

Canopy
AbbVie Latest to Commit to New US Manufacturing Growth Projects, Committing $195 Million to Expand API Capabilities
August 13th 2025

AbbVie Latest to Commit to New US Manufacturing Growth Projects, Committing $195 Million to Expand API Capabilities

Don Tracy, Associate Editor
Stock.adobe.com
August 13th 2025

Texas Sues Eli Lilly for Allegedly Bribing Providers to Prescribe Drugs

Mike Hollan